W. Taylor Cottle, PhD Candidate, HBN President The Hopkins Biotech Network continues to work towards building its network with industry and local leaders in the Baltimore Biotech and Pharma space….
Read More
BCI Fall Internships & VC Info Session Intrigued by VC or on the hunt for internships? Please see the attached flyers and links for information for the upcoming BCI internship opportunities and…
Hopkins Biotech Podcast: “Lauren Lee – Biotech Investing” Ever wondered if you could apply your scientific acumen to helping healthcare companies grow? Check out the latest episode of Hopkins Biotech Podcast, featuring Lauren Lee, Associate at Solasta…
JHU P.h.D Professional Development Workshop Series are delighted to announce the third professional development workshop, “Negotiation Strategies for Professional Success,” which will take place on July 9, 2020 from noon…
Hopkins Biotech Podcast: “Bernat Navarro-Serer – Shaping Science Policy” Ever considered deploying science to shape public policy? Check out the latest episode of Hopkins Biotech Podcast, featuring Bernat Navarro-Serer, Eastern Hub Co-Chair at the National Science Policy…
The iCAN speaker series is a great place to start your career planning. During this virtual career panel, hear from JHU alumni and other PhD professionals about their careers in…
Roshan Chikarmane, Co-Director of Alumni Relations, Ph.D. Candidate at Johns Hopkins School of Medicine Curious about career opportunities for life science students in pharmaceuticals, biotechnology, consulting, venture capital, and other…
John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone infected with cowpox to inoculate…
Tawny Hammett, M.S. Individualized Genomics & Health Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of tenuous recovery, bringing a welcomed…
Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger RNA-based vaccines and therapies –…
